Menu

Filtros : "MIELOMA MÚLTIPLO" "Storpirtis, Silvia" Removido: "2014" Limpar

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses (2017)

    Aguiar, Patrícia Melo ; Lima, Tácio de Mendonça; Colleoni, Gisele Wally Braga; Storpirtis, Silvia

    Source: Critical Reviews in Oncology Hematology. Unidade: FCF

    Subjects: MIELOMA MÚLTIPLO, ANTINEOPLÁSICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      AGUIAR, Patrícia Melo et al. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, v. 113, p. 195-212, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.critrevonc.2017.03.014. Acesso em: 11 out. 2024.

    • APA

      Aguiar, P. M., Lima, T. de M., Colleoni, G. W. B., & Storpirtis, S. (2017). Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses. Critical Reviews in Oncology Hematology, 113, 195-212. doi:10.1016/j.critrevonc.2017.03.014

    • NLM

      Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014

    • Vancouver

      Aguiar PM, Lima T de M, Colleoni GWB, Storpirtis S. Efficacy and safety of bortezomib, thalidomide, and lenalidomide in multiple myeloma: an overview of systematic reviews with meta-analyses [Internet]. Critical Reviews in Oncology Hematology. 2017 ; 113 195-212.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.critrevonc.2017.03.014

  • Artigo de periodico

    Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? (2016)

    Aguiar, Patrícia Melo ; Lima, T M; Storpirtis, Silvia

    Source: Journal of Clinical Pharmacy and Therapeutics. Unidade: FCF

    Subjects: MIELOMA MÚLTIPLO, ANTINEOPLÁSICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      AGUIAR, Patrícia Melo e LIMA, T M e STORPIRTIS, Silvia. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality?. Journal of Clinical Pharmacy and Therapeutics, v. 41, n. 2, p. 189-197, 2016Tradução . . Disponível em: https://doi.org/10.1111/jcpt.12384. Acesso em: 11 out. 2024.

    • APA

      Aguiar, P. M., Lima, T. M., & Storpirtis, S. (2016). Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? Journal of Clinical Pharmacy and Therapeutics, 41( 2), 189-197. doi:10.1111/jcpt.12384

    • NLM

      Aguiar PM, Lima TM, Storpirtis S. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2016 ; 41( 2): 189-197.[citado 2024 out. 11 ] Available from: https://doi.org/10.1111/jcpt.12384

    • Vancouver

      Aguiar PM, Lima TM, Storpirtis S. Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality? [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2016 ; 41( 2): 189-197.[citado 2024 out. 11 ] Available from: https://doi.org/10.1111/jcpt.12384
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024